Adipokines and cardiovascular risk in Cushing's syndrome (Q37953199)

25 August 2017

Adipokines and cardiovascular risk in Cushing's syndrome (English)

1 reference

25 August 2017

Anne Klibanski

3

1 reference

25 August 2017

Elena Valassi

1

1 reference

PubMed ID

22057123

25 August 2017

Beverly M K Biller

series ordinal

2

1 reference

PubMed ID

22057123

25 August 2017

Madhusmita Misra

series ordinal

4

1 reference

25 August 2017

3 November 2011

1 reference

25 August 2017

1 reference

25 August 2017

95

1 reference

25 August 2017

3

1 reference

25 August 2017

187-206

1 reference

The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states

25 August 2017

1 reference

Morbidity and mortality in Cushing's disease: an epidemiological approach

21 January 2018

1 reference

The metabolic syndrome and cardiovascular risk in Cushing's syndrome

21 January 2018

1 reference

Computed tomography assessment of fat distribution in male and female patients with Cushing's syndrome.

21 January 2018

1 reference

Body composition and metabolic features in women with adrenal incidentaloma or Cushing's syndrome

21 January 2018

1 reference

Assessment of GH reserve before and after successful treatment of adult patients with Cushing's syndrome

21 January 2018

1 reference

Regulation of hypothalamic somatostatin, growth hormone-releasing hormone, and growth hormone receptor messenger ribonucleic acid by glucocorticoids.

21 January 2018

1 reference

Glucocorticoid inhibition of growth in rats: partial reversal with somatostatin antibodies

21 January 2018

1 reference

Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome.

21 January 2018

1 reference

Persistence of increased cardiovascular risk in patients with Cushing's disease after five years of successful cure.

21 January 2018

1 reference

Clinical features of GH deficiency and effects of 3 years of GH replacement in adults with controlled Cushing's disease.

21 January 2018

1 reference

Baseline characteristics and the effects of two years of growth hormone replacement therapy in adults with growth hormone deficiency previously treated for Cushing's disease.

21 January 2018

1 reference

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

Leptin resistance: a possible interface of inflammation and metabolism in obesity-related cardiovascular disease

21 January 2018

1 reference

Glucose-dependent regulation of cholesterol ester metabolism in macrophages by insulin and leptin

21 January 2018

1 reference

Adipokines, insulin resistance, and coronary artery calcification

21 January 2018

1 reference

Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).

21 January 2018

1 reference

Leptin Inhibition of the Hypothalamic-Pituitary-Adrenal Axis in Response to Stress

21 January 2018

1 reference

Corticotropin-releasing factor and adrenocorticotrophic hormone as potential central mediators of OB effects

21 January 2018

1 reference

Leptin inhibits directly glucocorticoid secretion by normal human and rat adrenal gland

21 January 2018

1 reference

Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice

21 January 2018

1 reference

Leptin and the regulation of the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

Hypothalamic corticotropin-releasing hormone is a mediator of the anorexigenic effect of leptin

21 January 2018

1 reference

Leptin effects on the expression of type-2 CRH receptor mRNA in the ventromedial hypothalamus in the rat.

21 January 2018

1 reference

Effects of leptin and corticosterone on the expression of corticotropin-releasing hormone, agouti-related protein, and proopiomelanocortin in the brain of ob/ob mouse

21 January 2018

1 reference

Quantitative expression analysis of genes regulated by both obesity and leptin reveals a regulatory loop between leptin and pituitary-derived ACTH.

21 January 2018

1 reference

The role of neuropeptide Y in the antiobesity action of the obese gene product

21 January 2018

1 reference

Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene

21 January 2018

1 reference

Human leptin levels are pulsatile and inversely related to pituitary-adrenal function.

21 January 2018

1 reference

Characterization of leptin pulse dynamics and relationship to fat mass, growth hormone, cortisol, and insulin

21 January 2018

1 reference

Gender differences in both spontaneous and stimulated leptin secretion by human omental adipose tissue in vitro: dexamethasone and estradiol stimulate leptin release in women, but not in men.

21 January 2018

1 reference

Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects

21 January 2018

1 reference

The acute effect of dexamethasone on plasma leptin concentrations and the relationships between fasting leptin, the IGF-I/IGFBP system, dehydroepiandrosterone, androstenedione and testosterone in an elderly population.

21 January 2018

1 reference

Effect of small doses of dexamethasone on plasma leptin levels in normal and obese subjects: A dose-response study

21 January 2018

1 reference

Sexual dimorphism in circulating leptin concentrations is not accounted for by differences in adipose tissue distribution

21 January 2018

1 reference

Leptin secretion from subcutaneous and visceral adipose tissue in women.

21 January 2018

1 reference

Induction of leptin receptor expression in the liver by leptin and food deprivation

21 January 2018

1 reference

Regulation of circulating soluble leptin receptor levels by gender, adiposity, sex steroids, and leptin: observational and interventional studies in humans

21 January 2018

1 reference

Hormonal and body composition predictors of soluble leptin receptor, leptin, and free leptin index in adolescent girls with anorexia nervosa and controls and relation to insulin sensitivity

21 January 2018

1 reference

Diurnal and ultradian dynamics of serum adiponectin in healthy men: comparison with leptin, circulating soluble leptin receptor, and cortisol patterns

21 January 2018

1 reference

Serum immunoreactive-leptin levels are increased in patients with Cushing's syndrome

21 January 2018

1 reference

Glucocorticoid regulation of leptin synthesis and secretion in humans: elevated plasma leptin levels in Cushing's syndrome

21 January 2018

1 reference

Plasma leptin levels do not change in patients with Cushing's disease shortly after correction of hypercortisolism.

21 January 2018

1 reference

Leptin secretion in Cushing's syndrome: preservation of diurnal rhythm and absent response to corticotropin-releasing hormone

21 January 2018

1 reference

Determinants of serum leptin levels in Cushing's syndrome.

21 January 2018

1 reference

Hyperleptinemia in women with Cushing's disease is driven by high-amplitude pulsatile, but orderly and eurhythmic, leptin secretion

21 January 2018

1 reference

Both fasting-induced leptin reduction and GH increase are blunted in Cushing's syndrome and in simple obesity

21 January 2018

1 reference

Adipokine levels in Cushing's syndrome; elevated resistin levels in female patients with Cushing's syndrome.

21 January 2018

1 reference

Leptin and soluble leptin receptor levels in obese and weight-losing individuals

21 January 2018

1 reference

Effects of prolonged hyperinsulinemia on serum leptin in normal human subjects

21 January 2018

1 reference

Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss

21 January 2018

1 reference

Interleukin-1 receptor antagonist is associated with fat distribution in endogenous Cushing's syndrome: a longitudinal study

21 January 2018

1 reference

Serum leptin is increased in growth hormone-deficient adults: relationship to body composition and effects of placebo-controlled growth hormone therapy for 1 year

21 January 2018

1 reference

Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone

21 January 2018

1 reference

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

21 January 2018

1 reference

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

21 January 2018

1 reference

Selective downregulation of the high molecular weight form of adiponectin in hyperinsulinemia and in type 2 diabetes: differential regulation from nondiabetic subjects

21 January 2018

1 reference

Measurement of the high-molecular weight form of adiponectin in plasma is useful for the prediction of insulin resistance and metabolic syndrome

21 January 2018

1 reference

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

21 January 2018

1 reference

Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes

21 January 2018

1 reference

Plasma adiponectin levels and risk of myocardial infarction in men.

21 January 2018

1 reference

Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA.

21 January 2018

1 reference

11beta-hydroxysteroid dehydrogenase type 1 and obesity

21 January 2018

1 reference

Adipocyte-specific glucocorticoid inactivation protects against diet-induced obesity

21 January 2018

1 reference

Role of metabolically active hormones in the insulin resistance associated with short-term glucocorticoid treatment

21 January 2018

1 reference

Ghrelin and adiponectin in patients with Cushing's disease before and after successful transsphenoidal surgery

21 January 2018

1 reference

Effects of short-term corticoid ingestion on food intake and adipokines in healthy recreationally trained men.

21 January 2018

1 reference

Effect of glucocorticoids on adiponectin: a study in healthy subjects and in Cushing's syndrome

21 January 2018

1 reference

Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-alpha expression

21 January 2018

1 reference

Serum adiponectin levels in adult growth hormone deficiency and acromegaly.

21 January 2018

1 reference

Different effects of short- and long-term recombinant hGH administration on ghrelin and adiponectin levels in GH-deficient adults

21 January 2018

1 reference

The hormone resistin links obesity to diabetes

21 January 2018

1 reference

Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators

21 January 2018

1 reference

Resistin - a mediator of obesity-associated insulin resistance or an innocent bystander?

21 January 2018

1 reference

Resistin promotes smooth muscle cell proliferation through activation of extracellular signal-regulated kinase 1/2 and phosphatidylinositol 3-kinase pathways.

21 January 2018

1 reference

Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions

21 January 2018

1 reference

Resistin is an inflammatory marker of atherosclerosis in humans.

21 January 2018

1 reference

Influence of leptin, adiponectin, and resistin on the association between abdominal adiposity and arterial stiffness

21 January 2018

1 reference

Resistin, adiponectin, and risk of heart failure the Framingham offspring study

21 January 2018

1 reference

Plasma resistin levels and risk of myocardial infarction and ischemic stroke

21 January 2018

1 reference

Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells

21 January 2018

1 reference

Tumor necrosis factor alpha is a negative regulator of resistin gene expression and secretion in 3T3-L1 adipocytes

21 January 2018

1 reference

Pituitary resistin gene expression is upregulated in vitro and in vivo by dexamethasone but is unaffected by rosiglitazone

21 January 2018

1 reference

Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner.

21 January 2018

1 reference

Adipokine levels and cardiovascular risk in patients with adrenal incidentaloma

21 January 2018

1 reference

The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance

21 January 2018

1 reference

GH is a positive regulator of tumor necrosis factor alpha-induced adipose related protein in 3T3-L1 adipocytes

21 January 2018

1 reference

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

21 January 2018

1 reference

"Vasocrine" signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease.

21 January 2018

1 reference

Atherosclerosis — An Inflammatory Disease

21 January 2018

1 reference

Inflammatory markers and onset of cardiovascular events: results from the Health ABC study

21 January 2018

1 reference

TNF-alpha facilitates inflammation-induced glucocorticoid secretion in rats with biliary obstruction

21 January 2018

1 reference

Interactions between tumor necrosis factor-alpha, hypothalamic corticotropin-releasing hormone, and adrenocorticotropin secretion in the rat.

21 January 2018

1 reference

Tumor necrosis factor alpha inhibits the hormonal response of the pituitary gland to hypothalamic releasing factors

21 January 2018

1 reference

Does central obesity reflect "Cushing's disease of the omentum"?

21 January 2018

1 reference

Effect of dexamethasone on adipocyte differentiation markers and tumour necrosis factor-alpha expression in human PAZ6 cells.

21 January 2018

1 reference

Stress hormones, proinflammatory and antiinflammatory cytokines, and autoimmunity

21 January 2018

1 reference

Relative growth hormone deficiency and cortisol excess are associated with increased cardiovascular risk markers in obese adolescent girls.

21 January 2018

1 reference

Raised serum levels of interleukin-8 and interleukin-18 in relation to bone metabolism in endogenous Cushing's syndrome

21 January 2018

1 reference

The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation

21 January 2018

1 reference

Alterations of monocyte function in patients with growth hormone (GH) deficiency: effect of substitutive GH therapy

21 January 2018

1 reference

Circulating interleukin-6 in relation to adiposity, insulin action, and insulin secretion

21 January 2018

1 reference

Regulation of adipocytokines and insulin resistance

21 January 2018

1 reference

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

21 January 2018

1 reference

Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?

21 January 2018

1 reference

Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation

21 January 2018

1 reference

Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells.

21 January 2018

1 reference

Effects of glucocorticoids and chronic inflammatory stress upon anterior pituitary interleukin-6 mRNA expression in the rat.

21 January 2018

1 reference

Serum interleukin-6 in patients with adrenal tumors

21 January 2018

1 reference

Plasma angiotensinogen concentrations in obese patients.

21 January 2018

1 reference

Regulation by glucocorticoids of angiotensinogen gene expression and secretion in adipose cells

21 January 2018

1 reference

A transgenic model of visceral obesity and the metabolic syndrome

21 January 2018

1 reference

Hormonal regulation of the human adipose-tissue renin-angiotensin system: relationship to obesity and hypertension

21 January 2018

1 reference

Regulation of 11beta-HSD genes in human adipose tissue: influence of central obesity and weight loss

21 January 2018

1 reference

Role of peripherally infused angiotensin II on the human hypothalamic–pituitary–adrenal axis

21 January 2018

1 reference

Effect of angiotensin II on adrenal and pituitary function in man.

21 January 2018

1 reference

Suppression of plasma ACTH concentration by angiotensin II infusion in normal humans and in a subject with a steroid 17 alpha-hydroxylase defect

21 January 2018

1 reference

Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the insulin resistance atherosclerosis study

21 January 2018

1 reference

Plasminogen activator inhibitor-1, inflammation, obesity, insulin resistance and vascular risk

21 January 2018

1 reference

11beta-Hydroxysteroid dehydrogenase type 1-driven cortisone reactivation regulates plasminogen activator inhibitor type 1 in adipose tissue of obese women

21 January 2018

1 reference

Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin

21 January 2018

1 reference

Non-acylated ghrelin counteracts the metabolic but not the neuroendocrine response to acylated ghrelin in humans.

21 January 2018

1 reference

Ghrelin suppresses cardiac sympathetic activity and prevents early left ventricular remodeling in rats with myocardial infarction

21 January 2018

1 reference

Ghrelin inhibits proinflammatory responses and nuclear factor-kappaB activation in human endothelial cells

21 January 2018

1 reference

Cardiovascular effects of intravenous ghrelin infusion in healthy young men.

21 January 2018

1 reference

Vasodilatory effect of ghrelin, an endogenous peptide from the stomach

21 January 2018

1 reference

Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.

21 January 2018

1 reference

Mediation by the central nervous system is critical to the in vivo activity of the GH secretagogue L-692,585.

21 January 2018

1 reference

Ghrelin stimulates adrenocorticotrophic hormone (ACTH) secretion by human ACTH-secreting pituitary adenomas in vitro.

21 January 2018

1 reference

Differential expression of ghrelin and its receptor (GHS-R1a) in various adrenal tumors and normal adrenal gland.

21 January 2018

1 reference

Cellular distribution and regulation of ghrelin messenger ribonucleic acid in the rat pituitary gland.

21 January 2018

1 reference

Endogenous and exogenous glucocorticoids decrease plasma ghrelin in humans.

21 January 2018

1 reference

The negative association between total ghrelin levels, body mass and insulin secretion is lost in hypercortisolemic patients with Cushing's disease

21 January 2018

1 reference

Plasma ghrelin concentrations are decreased in insulin-resistant obese adults relative to equally obese insulin-sensitive controls

21 January 2018

1 reference

Systemic ghrelin levels in subjects with growth hormone deficiency are not modified by one year of growth hormone replacement therapy.

21 January 2018

1 reference

Serum ghrelin levels are suppressed in hypopituitary patients following insulin-induced hypoglycaemia irrespective of GH status.

21 January 2018

1 reference

Enhanced inflammatory response in patients with preinfarction unstable angina

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000330416

1 reference

25 August 2017

1 reference

PubMed ID

22057123